Blood Purification Systems
SARS-CoV-2 infections develop into serious disease in about 13.8% of cases and critical disease in 6.1%. Patients may develop sepsis, acute respiratory distress syndrome and/or multi-organ failure. This has prompted researchers to look at alternative methods to treat critically ill COVID-19 patients, including administration of convalescent plasma, plasma transfusion and blood purification. Plasma transfusion and blood purification therapies are aimed at treating the systemic response. Learn more by accessing this document.